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CytotoxicityThe safety and effectiveness of many of the medicinal plants used in traditional medicine by rural people with
little or no access to allopathic drugs is yet to be evaluated. With this in mind, Ozoroa and Searsia (previously
known as Rhus) species traditionally used in South Africa to treat microbial infections and gastrointestinal
disorders were selected for in vitro evaluation of biological activities and cytotoxicity.
Phenolic-enriched leaf extracts were prepared using mixture of 1% HCl acidiﬁed 70% acetone and n-hexane. The
crude extract was further fractionatedwith solvent of different polarities. Crude extracts and fractionswere test-
ed against Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Enterococcus faecalis, Aspergillus
fumigatus, Candida albicans and Cryptococcus neoformans. In addition, the antioxidant potentialswere determined
byDPPH, ABTS, hydroxyl radical scavenging and linoleic acid peroxidation inhibition. The cytotoxic activity of the
crude extracts was assayed against Vero cells.
The crude extract and the various fractions had good biological activities. The most noteworthy activity is the
growth inhibition of the hexane and dichloromethane fractions with MIC values as low as 19 μg/ml. The ethyl
acetate and butanol fractions had moderate to low antimicrobial activities with MICs ranging from 39 to
2500 μg/ml. The polar fractions were more active against the fungal pathogens compared with the non-polar
fraction. In the DPPH antioxidant assays, the active compounds were concentrated in the polar fractions (IC50
of the crude extract ranged between 0.90 and 15.82 μg/ml). The ethyl acetate fraction was the most active
(IC50 ranging between 0.84 and 7.92 μg/ml). Although thewater fraction was themost polar, the antioxidant ac-
tivities were low due to the transfer of the active components into the ethyl acetate and butanol fractions. The
crude extracts also had good linoleic acid peroxidation inhibition (LC50 ranging between 13.99 and 40.45 μg/ml).
Crude extracts and fractions of the Ozoroa mucronata, O. paniculosa, Searsia leptodictya, S. pendulina, and
S. pentheri species tested in this study had good activities relating to diarrhoea mechanisms of pharmacological
relevance. However, use of phenolic-enriched crude extracts from these plants for diarrhoeal treatment or any
other diseases need to be applied with caution as most of the plant extracts were reasonably toxic against
Vero cell line. A next step in the possible application of these extracts to treat diarrhoea would be to identify
the bioactive and toxic compounds.
© 2014 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
The use of medicinal plants to alleviate diarrhoeal symptoms is a
common practice in South African Traditional Medicine (McGaw et al.,
2000). More than 80% of the rural populations and urban settlements
still rely on traditional medicine for healthcare delivery. Aside from
being the backbone of ethnomedicine, plant phytochemicals have alsoe, Department of Paraclinical
f Pretoria, Private Bag X04,
023.
d).
hts reserved.been a major source of drugs or drug templates used in modern medi-
cine. In an outbreak of diarrhoea, decoctions, concoctions or infusions
of the medicinal plants are taken three or four times a day, until the
symptoms are resolved, though the dosage is not controlled in most
cases (Arnold and Gulumian, 1984).
Diarrhoeal symptoms are a consequence of altered intestinal motil-
ity and ﬂuid accumulation in the gastrointestinal tract (GIT). These con-
ditions are usually caused by microbial infections, intestinal parasitic
burdens, intestinal inﬂammation, stress (physical and oxidative), or
manifestation of other forms of diseases such as ulcerative colitis
(Westbrook et al., 2010), Crohn's disease (Lomax et al., 2006), diabetes
(Forgacs and Patel, 2011) and malaria (Gessler et al., 1995). Chronic
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in cases of human immunodeﬁciency virus/acquired immune deﬁciency
syndrome (HIV/AIDS) where patients are susceptible to opportunistic
infections including diarrhoeal pathogens (Dworkin et al., 1985). One
of the consequences of diarrhoea in HIV/AIDS patients is the reduction
of the absorption and bioavailability of anti-retroviral drugs. South
Africa has the largest HIV infection rate in the world and many patients
depend on medicinal plants to get relief from diarrhoea and intestinal
disorders. In infants, diarrhoea may cause malnutrition, resulting in
stunted growth, a defective immune system and increased susceptibili-
ty to other infections (Fleckenstein et al., 2010).
Economically, diarrhoea is one of the major health challenges to
humans as it causes loss of productive life due to premature mortality,
disability and increased health-care costs (Guerrant et al., 2005). In an-
imal production, diarrhoea symptoms are presumed to impose heavy
productivity losses on affected farms, although the true effects in mon-
etary terms cannot be easily appreciated. The apparent on-farm losses
are reduction in productivity (milk, wool, egg, meat and meat quality),
increased mortality and morbidity, weight loss and abortion (Chi
et al., 2002). Episodes of diarrhoeal diseases can also affect the export
market and hurt consumers' conﬁdence in the products (Yarnell,
2007). Oddly enough, diarrhoea can be considered physiologically ben-
eﬁcial to the GIT as it provides an important mechanism of ﬂushing
away harmful luminal substances (Valeur et al., 2009). However, diar-
rhoea becomes pathological and fatal when the loss of ﬂuids and elec-
trolytes exceeds the body's ability to replace the losses.
The most common modern way of managing diarrhoeal symptoms
is ﬂuid replacement in combination with pharmacological therapy.
Fluid and electrolyte replacement is used to replace ﬂuid losses by ad-
ministrating sugar-electrolyte solution, usually referred to as oral rehy-
dration therapy (ORT), as supportive treatment (Thapar and Sanderson,
2004). However, ORT does not facilitate the re-absorption or lessen the
secretion of ﬂuid, and therefore cannot stop diarrhoea but only reduce
adverse effects that may result in death. Symptomatic treatment with
antimicrobial or supportive therapy with preparations, compounds
and drugs possessing antispasmodic, antimotility, antioxidant, anti-
secretory/pro-absorptive, antitoxin and anti-inﬂammatory properties,
depending on the causative agents, can be used in alleviating and
treatingdiarrhoea (Wynnand Fougere, 2007). In cases of established in-
fectious pathogens, speciﬁc therapeutic intervention using antimicrobi-
al agents targeting the causative microbes may be applied as standard
therapy. These standard therapeutic options are insufﬁcient because of
limited available modalities with broad based activities against the
large numbers of diarrhoeal mechanism and apparent side effects
(Ryu et al., 2004).
In aerobic living systems, oxidative species are generated endoge-
nously in processes such as oxidative phosphorylation in mitochondria,
livermixed function oxidases,microbial phagocytosis, xanthine oxidase
activity, transition metal catalysis, drugs and xenobiotic metabolism.
These oxidative species create homeostatic imbalance which generate
oxidative stress resulting in tissue injury and cell death (Kumar and
Kakkar, 2008). Oxidative damage in the human and animals plays an
important causative role in the initiation and progression of diseases.
These include inﬂammation, microbial infection, autoimmune pa-
thology, and gastrointestinal disorders such as diarrhoea through
cytotoxic by-products of intestinal mucosal membrane lipid peroxi-
dation. To overcome the deleterious effects of oxidative stress, mul-
tiple defence systems commonly referred to as antioxidants are
inherent in living organisms. The protective efﬁciency depends on
the balance between oxidative species and bioavailability of antiox-
idants in the microenvironment of a cell (Mathew and Abraham,
2006). However, endogenously antioxidant mechanisms may not
be enough to remove the oxidative species, therefore additional an-
tioxidant frommedicinal plant or food source are needed. Medicinal
plant preparations are used for treating more than one disease and
probably had high bioactivity against common aetiologies.The plant kingdom provides a non-exhaustive source of natural
phytochemicals with bioactivity efﬁcient in different applications
for treating health disorders and maintenance of good health.
Many plant species from the Ozoroa and Searsia (syn. Rhus) genera
in the Anacardiaceae family such as Ozoroa insignis (Liu and Abreu,
2006), Ozoroa reticulata (Maregesi et al., 2007), Ozoroa mucronata
(Yamagiwa et al., 1987), Ozoroa obovata (Bandeira et al., 2001), Ozoroa
sphaerocarpa (Sibandze et al., 2010), Ozoroa paniculosa, Searsia lancea,
Searsia incisa (Van der Merwe et al., 2001; McGaw and Eloff, 2008),
Searsia javanica (Vareinshang and Yadav, 2004), Searsia natalensis
(Johns et al., 1995), Searsia gueinzii (Elgorashi et al., 2003), Searsia
leptodictya diels (Sebothoma, 2010), Searsia rogersii Schonland (Samie
et al., 2010), and Searsia pendulina (Coates-Palgrave, 2002) are used
by traditional medicine practitioners in South Africa and other African
countries for treating intestinal disorders, including diarrhoea. The
antidiarrhoeal activities of these plants may be due to synergistic or in-
dividual components acting on one or more mechanisms of diarrhoea.
Searsia pentheri is reported to be used to cure epilepsy in Zululand of
South Africa (Svenningsen et al., 2006). However, S. javanica is the
only species studied for antidiarrhoeal properties (Vareinshang and
Yadav, 2004), although the antimicrobial of many Ozoroa and Searsia
species have been reported in the literature.
Phytochemical evaluations of several species from the family have
led to isolation of many bioactive compounds such as anacardic acid
from O. mucronata and O. paniculosa. This compound has been reported
to possess anti-inﬂammatory properties by inhibition of LOX (Ha and
Kubo, 2005) and PG synthase inhibition (Kubo et al., 1987). Isolation
of moronic acid as an antimicrobial principle from O. mucronata has
also been reported (Hostettmann-Kaldas and Nakanishi, 1979).
Alongside themedicinal beneﬁcial constituents, plants also have the
capacity to produce some potentially toxic compounds and therefore
attention needs to be focused on the safety of plant preparations. How-
ever, a literature search on the biological and phytochemical evaluation
of some of these species generated little information. The aims of this
work were to scientiﬁcally validate and evaluate the pharmacological
properties of O. mucronata, O. paniculosa, S. leptodictya, S. pendulina,
and S. pentheri against some diarrhoeal aetiology. Therefore, the antimi-
crobial activities of leaf extracts against some microbes associated with
diarrhoea; the antioxidant activity of the extract using various standard
protocols, the phenolic composition of the extracts, anti-inﬂammation
through the soybean 15-lipoxygenase enzyme inhibition and the cyto-
toxicity of the extracts using an in vitro Vero cell line model were
evaluated.
2. Materials and methods
2.1. Plant collection
The species investigated were selected based on traditional use and
availability in the University Botanical Garden and leaves were in-
vestigated because it represents a sustainable resource. The leaves
of O. mucronata (Bernh.) R.Fern & A.Fern (Ozm), O. paniculosa
(Sond.) R.Fern. & A.Fern. (Ozp), S. leptodictya (Diels) T.S.Yi, A.J.Mill.
& J.Wen (Sle), S. pendulina (Jacq.) Moffett, comb. nov. (Spd), and
S. pentheri (Zahlbr.) Moffett (Spt) were collected from the University of
Pretoria's Manie van der Schijff Botanical Garden. The plant material
was identiﬁed and authenticated by Lorraine Middleton and Magda
Nel at the University of Pretoria. The voucher specimen numbers for
the herbarium specimens deposited at the H.G.W.J. Schweickerdt Her-
barium (University of Pretoria) are PRU 68928, PRU 66851, PRU 70151,
PRU 84141 and PRU 709769 for Ozm, Ozp, Sle, Spd, and Spt respectively.
2.2. Preparation of extracts
The polyphenolic-enriched leaf extracts of Ozm, Ozp, Sle, Spd and
Spt were prepared by simultaneous extraction and fractionation of 20
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0.1% HCl (Naczk and Shahidi, 2004) and 200 ml of n-hexane for 12 h.
The phenolic and glycosides enriched aqueous phase lower phase frac-
tion was separated from the chlorophyll and triterpenoid enriched n-
hexane upper phase fraction. This was repeated twice and n-hexane
fractions were combined. The combined aqueous fraction was fraction-
ated using solvent of increasing polarity to obtain dichloromethane
(DCM), ethyl acetate (ETOAc), butanol (BuOH) and residual water frac-
tions. The crude extract and various fractions were concentrated under
reduced pressure using rotary evaporator (Buchi). The organic fractions
of n-hexane, DCM, ETOAc andBuOHwere air dried at room temperature
for 72 hwhile the crude extract and residualwater fractionwere freeze-
dried. The dried crude extract and fractions were reconstituted in ace-
tone and 70% acetone at a concentration of 10 mg/ml for the bioassays.
2.3. Antimicrobial assays
2.3.1. Minimum inhibitory concentration (MIC) determination against
bacteria
The minimum inhibitory concentration (MIC) values for the crude
extracts against Staphylococcus aureus (ATCC 29213), Pseudomonas
aeruginosa (ATCC 27853), Escherichia coli (ATCC 25922) and Enterococ-
cus faecalis (ATCC 29212) were evaluated using the serial dilution assay
with tetrazolium violet added as growth indicator (Eloff, 1998).
Overnight cultures of the bacteria (S. aureus, 2.6 × 1012 cfu/ml;
E. faecalis, 1.5 × 1010 cfu/ml; P. aeruginosa, 5.2 × 1013 cfu/ml and
E. coli, 3.0 × 1011 cfu/ml) were ten-fold diluted with sterilised
Mueller-Hinton (MH) broth. The extracts (100 μl at 10 mg/ml) were se-
rially diluted two-fold with sterile water in a sterile 96-well microtitre
plate for each organism, and 100 μl of the bacterial culture was added
to eachwell. The plateswere sealedwith transparent paraﬁlm and incu-
bated at 37 °C for 24 h. TheMIC values were obtained by adding 40 μl of
0.2 mg/ml INT and inhibitory activity read after 30 min and 12 h. The
screening was done in triplicate and repeated twice, and where there
were variations, the experiment was repeated again. Gentamicin
(concentration ranges from 25 μg/ml in the ﬁrst well to 0.19 μg/ml in
the last well) and 70% acetone solution were used as positive and
negative control respectively.
2.3.2. Minimum inhibitory concentration (MIC) determination against
fungi
Minimum inhibitory concentrations (MIC) against three pathogenic
and opportunistic fungi were determined using the serial dilution
assay (Eloff, 1998) and with some modiﬁcations (Masoko et al.,
2005). The organisms tested were Aspergillus fumigatus, Candida
albicans, and Cryptococcus neoformans. Overnight cultures of the
fungi (C. albicans, 2.5 × 106 cfu/ml, A. fumigatus, 8.1 × 106 cfu/ml
and C. neoformans, 2.6 × 106 cfu/ml) were ten-fold diluted with
sterilised Sabouraud broth. The extracts (100 μl at 10 mg/ml) were
prepared by two-fold serial dilution with sterile water in a sterile
96-well microtitre plate for each organism. Then, 100 μl of the fungal
culture and 40 μl of 0.2 mg/ml INT were added to each well. The
plates were sealed with transparent paraﬁlm and incubated at 37 °C.
The MICs were read after 24 h and 48 h respectively. The screening
was done in triplicate and repeated twice, and where there were varia-
tions, the experiment was repeated again. Amphotericin B (concentra-
tion ranges from 50 μg/ml in the ﬁrst well to 0.39 μg/ml in the last
well) and 70% acetone solution were used as positive and negative
controls respectively.
2.4. Antioxidative assays
2.4.1. 2, 2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay
Radical scavenging activity of the extracts and fractionswas estimat-
ed using 2, 2-diphenyl-1-picrylhydrazyl (DPPH) (Brand-Williams et al.,
1995) with some modiﬁcations to a 96-well microtitre plate. A 40 μl of0.3–500 μg/ml of crude extracts, fractions and controls (trolox and
ascorbic acid) were added to 160 μl of a 25 mg/L solution of DPPH in a
96-well microtitre plate. After incubation in the dark for 30min, the ab-
sorbance of each test samplewas read at 516nmusingVersamaxmicro-
titre plate reader.
2.4.2. 2, 2′-Azinobis-(3-ethylbenzothiazoline-6-sulfonic acid (ABTS) radical
decolourisation assay
The free radical decolourisation assay using 2, 2′-azinobis-(3-ethyl-
benzothiazoline-6-sulfonic acid (ABTS) of the crude extract, fractions
and controls was performed with modiﬁcation to 96-well microtitre
plate format (Re et al., 1999). ABTS free radical was generated in 75%
methanol solution by mixing ABTS solution at 7 mM concentration
and potassium persulfate at 2.45 mM, and placed in the dark for
12–16 h at room temperature. For the assay, the ABTS solution was di-
luted to absorbance value range of 0.70 ± 0.02 at 734 nm and equili-
brated at room temperature (Ao). A 40 μl aliquot of 0.3–500 μg/ml of
crude extracts, fractions and controls (trolox and ascorbic acid) was
added to 160 μl of ABTS and the absorbance read after 6 min of mixing
(At). Theblankwas prepared the samewaywith dissolving solvent (Ab).
2.4.3. Hydroxyl radical scavenging assay
The hydroxyl radical scavenging activities of the test samples were
measured by the salicylic acid method with some modiﬁcations
(Smirnoff and Cumbes, 1989). The hydroxyl radical was generated
using the Fenton reaction by which 50 ml of FeCl3 (8.0 mM), 80 ml of
H2O2 and 50ml of distilled water was allowed to stand for 1 h. Themix-
ture was ﬁltered to remove the debris. The presence of the hydroxyl
radical was determined by mixing 120 μl of the hydroxyl radical solu-
tion with 66 μl of each extract followed by 14 μl of salicylic acid (20
mM). The mixture was incubated for 30 min at 37 °C and absorbance
taken at 510 nm.
2.4.4. Linoleic acid peroxidation inhibitory assay
Lipid peroxidation inhibitory activity of the crude extracts against
linoleic acid was determined as described by Kishida et al. (1993).
Each reaction mixture contained 4.1 ml of 2.5% linoleic acid in ethanol
and 10 ml of 0.2 M phosphate buffers (pH 7.4), and 1 ml of
0.0025 mg/ml FeSO4 was added as catalyst. Different concentrations of
the samples (0.01–500 mg/ml) were added to the reaction mixture in
a centrifuge tube. The reaction mixture was incubated at 40 °C for 2 h.
The reaction was terminated by adding 1 ml of 25% trichloroacetic
acid and 1 ml of 0.67% thiobarbituric acid. The reaction mixture was
heated at 95 °C for 30 min and then cooled for 15 min. The mixture
was extracted with butanol and absorbance measured at 500 nm.
2.5. In vitro cytotoxicity assay
Cytotoxicity of the extract was determined by the MTT [3-(4, 5-
dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide] assay
(Mosmann, 1983) using Vero African green monkey kidney cell lines.
The cells were cultured in Minimal Essential Medium (MEM) Earle's
Base, supplemented with 2 mM L-glutamine, 16.5 mM NaHCO3, 0.1%
gentamicin and 5% foetal calf serum. Conﬂuent monolayer culture sus-
pensions of the cells were seeded into 96-well tissue culture microtitre
plates at a density of 2 × 103 cells per well and incubated for 24 h at
37 °C in a 5% CO2 incubator. Extracts re-suspended in DMSO and diluted
in MEM, positive control (berberine chloride, Sigma) and negative con-
trol were added to the cells and incubated for 5 days. The cells were ob-
served using an inverted microscope to check for cytopathic effects
caused by the extract. The cell proliferation and viability was examined
by addition of 30 μl of a 5 mg/ml solution ofMTT in PBS to eachwell and
incubation for another 4 h at 37 °C. Themediumwas carefully removed
from the wells without disturbing the MTT concentrate and washed
twice with PBS. The liquid was aspirated from the cells and 50 μl of
DMSO was added to each well to dissolve the crystallised MTT
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570 nm using a Versamax microtitre plate reader. The results were
expressed as a percentage of the control cells and IC50 values were
calculated.
2.6. Phytochemical analysis
2.6.1. Determination of total phenolic constituents of the extracts
The total phenolic (TP) compositions of the crude extracts were
evaluated using the Folin–Ciocalteau method with some modiﬁcations
(Makkar, 2003). The extracts (50 μl) at a ratio of plant material: extract-
ant of 1:1 were made up to 500 μl with distilled water. Subsequently,
250 μl of commercial Folin–Ciocalteau reagent diluted with distilled
water (1:1) and 1250 μl of 20% sodium carbonate solution was added.
Absorbance was recorded at 725 nm after incubation for 40 min at
room temperature. The amount of polyphenols (expressed as mg
gallic acid/g dry weight) was calculated from a linear equation of
the standard curve (0.0019–0.25 mg/ml gallic acid) prepared at the
same time and the equation used was absorbance = 4.9022 × TP
(mg GAE), R2 = 0.9804.
2.6.2. Determination of total tannin
The total tannin (TT) content of the extracts was determined using
the polyvinylpyrrolidone (PVPP) binding method (Makkar, 2003). The
tannin-bound mixtures were prepared by mixing 100 mg of PVPP,
1ml of distilledwater and 1ml of phenolic-containing extracts in a cen-
trifuge tube. The mixtures were vortexed and refrigerated at 4 °C for
15 min and then ﬁltered. The ﬁltrate (100 μl) was transferred to a test
tube and the phenolic contents were evaluated as described in
Section 2.6.1. Non-tannin phenolic contents were determined from
the standard curve of catechin expressed as catechin equivalent in
mg/g dry material. The tannin content was calculated as the difference
between the total phenolic and non-phenolic content of the extracts
as the tannin constituents were bound and precipitated by PVPP.
2.6.3. Determination of proanthocyanidin
The proanthocyanidin (PA) content of the extracts was determined
using butanol-HCl reagent (Makkar, 2003). The extract (500 μl) was dis-
pensed into a test tube and made up to 10 ml with 70% acetone. A vol-
ume of 3 ml of butanol/HCl reagent (95:5 v:v) and 100 μl of 2% ferric
ammonium sulphate in 2 NHCl were added. The test tubeswere loosely
covered and heated in a boiling water bath for 50 min. The absorbance
was recorded at 550 nm after the tubes and contents were cooled to
room temperature. Absorbance of the unheated mixture was used as
blank.
2.6.4. Determination of condensed tannin
The condensed tannin (CT) content of the extracts was determined
using vanillin/HCl reagent (Heimler et al., 2006). The extract (0.5 ml)
was mixed with 3 ml of vanillin reagent containing 4% concentrated
HCl and 0.5% of vanillin in methanol in a test tube. The mixture was
allowed to stand at room temperature for 15 min and absorbance was
recorded at 500 nm against methanol as blank. The amount of con-
densed tannin in the extracts was expressed as catechin equivalent
(CE)/g dry plant material. The standard curve ranged from 0.0019 to
0.25 mg/ml and the equation used was absorbance = 0.1791 × CT
(mg CE) + 0.0504, R2 = 0.944.
2.6.5. Determination of hydrolysable tannin (gallotannin)
The hydrolysable tannin as gallotannin (GT) constituent of the ex-
tracts was determined with the potassium iodate assay (Vermerris
and Nicholson, 2006). The extract (3 ml) was mixed with 1 ml of satu-
rated solution of potassium iodate and allowed to stand at room tem-
perature for 40 min and absorbance was read at 550 nm. A standard
curve was prepared using gallic acid under the same conditions as the
extracts and results were expressed as gallic acid equivalent (GAE)/gdry plant material and the equation used was absorbance = 0.8264 ×
GT (mg GAE) + 0.0392, R2 = 0.9155.
2.6.6. Determination of total ﬂavonoids and ﬂavonol
The total ﬂavonoid (TF) content of the extracts was determined
using aluminium chloride solution with some modiﬁcations (Abdel-
Hameed, 2009). The extract (100 μl) was mixed with 100 μl of 20%
AlCl3, two drops of glacial acetic acid and 3ml of methanol. Themixture
was allowed to stand at room temperature for 40 min and absorbance
was read at 415 nm. Blank samples were prepared with the extract
without AlCl3. Standard curve was prepared using quercetin (3.9–
500 μg/ml) inmethanol under the same condition. The amount of ﬂavo-
noids was expressed as mg quercetin equivalent/g of dry plant material
(Absorbance = 4.9747 × FT (mg quercetin), R2 = 0.9846).
The ﬂavonol content (FLL) of the extracts was determined with
some modiﬁcations using aluminium chloride solution (Abdel-
Hameed, 2009). The extract (1 ml) was mixed with 1 ml of 20 mg/ml
of AlCl3 and 3 ml of 50 mg/ml of sodium acetate. The mixture was
allowed to stand at room temperature for 2.5 h and absorbance read
at 440 nm. A standard curve was prepared using quercetin (0.0019–
0.0312 mg/ml) in methanol under the same condition. The amount of
ﬂavonol was expressed as mg quercetin equivalent/g of dry plant
material and the equation used was absorbance = 34.046 × FLL
(mg quercetin), R2 = 0.9853.
2.7. Lipoxygenase inhibition
Inhibition of 15-lipoxygenase (15-LOX) was carried out using soy-
bean lipoxygenase type 1-B (Sigma South Africa) (Lyckander and
Malterud, 1992). Measurements of increase in absorbance at 234 nm
at intervals of 30 s for 5 min after enzyme addition were done in 0.2
M borate buffer (pH 9.00) with linoleic acid (134 μM) as substrate and
an enzyme concentration of 200 U/ml, using test substance solutions
in DMSO as blanks. All experiments were performed in triplicate.
Lipoxygenase inhibitory activity was expressed as the percentage inhi-
bition of lipoxygenase, calculated as (%) inhibition following the equa-
tion
%ð Þ inhibition ¼ C–TSð Þ=Cð Þ  100
where C is the change in absorbance of the assay without the plant ex-
tracts (control) and TS is the change in absorbance of the assay with the
plant extracts (test sample).
2.8. Statistical analysis
All values were expressed as mean ± SD. The sigmoidal dose–
response (variable slope) best ﬁt EC50 for each extracts and fractions
was computed with the associated standard error. The analysis was
performed using GraphPad Prism forWindows, version 5.03 (GraphPad
Software, San Diego, CA, USA). Statistical analysis of the results was
performed by using one way ANOVA, followed by Bonferroni multiple
comparison post hoc tests and the signiﬁcant difference was set at
P b 0.05.
3. Results and discussion
3.1. Yield
The percentage yield of the phenolic-enriched extracts and fractions
were determined as presented in Fig. 1. The percentage yields of the
crude extracts and fractions were expressed as the ratio of the dry
weight of plant extract to the dry weight of the plant material used for
the extraction process. Themaximum yield of the crude extract was ob-
tained from S. leptodictya (44.5 ± 3.47%) followed by O. paniculosa
(43.87 ± 2.60%) while S. pentheri gave the lowest yield (21.13 ±
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Fig. 1. Percentage yield of the crude extracts and fractions. Ozm (Ozoroamucronata); Ozp (O. paniculosa); Sle (Searsia leptodictya); Spd (S. pendulina); Spt (S. pentheri), TY (total yield), H f
(hexane fraction), DCM f (dichloromethane fraction), ETOAc f (ethyl acetate fraction), But f (butanol fraction), W met f (water fraction soluble in methanol).
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phenolic-enriched constituents considering the yields of the crude ex-
tracts. For the fractions, the yield varied according to the polarities of
the different compounds present in the crude extracts.
3.2. Phenolic constituents
In this study, the total phenolic, total tannin, condensed tannin, hy-
drolysable tannin as gallotannin, ﬂavonoids and ﬂavonol constituents
of the phenolic-enriched crude extracts are evaluated and the results
presented as equivalents of various standard compounds in Fig. 2. The
amount of total phenolics varied widely and ranged from 74.91 ±
1.26 mg GAE/g dried plant material in O. mucronata to 370.89 ±Phenolic constituent of cr
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Fig. 2. Phenolic constituent of the acidiﬁed 70% acetone leaf extracts of Ozoroa and Searsia
(S. pendulina); Spt (S. pentheri); TP (Total phenolic (mg GAE/g)), TT (Total tannin (mg GAE/g))
(mg LE/g)), GT (gallotannin (mg GAE/g)), TF (total ﬂavonoid (mg QE/g)), FLL (ﬂavonol (mg QE4.80 mg GAE/g dried plant material in O. paniculosa. For the Searsia spe-
cies, the highest amount of total phenolic content was obtained from
S. pendulina (339.80 ± 5.10 mg GAE/g dried plant material) followed
by S. leptodictya (324.78 ± 2.09 mg GAE/g dried plant material) and
the least amount found in S. pentheri (180.86 ± 3.68 mg GAE/g dried
plant material). Phenolic compounds are important bioactive compo-
nents of medicinal plant extracts exhibiting multifunctional pharmaco-
logical properties. These groups of phytochemicals are primarily natural
antioxidants which act as reducing agents, metal chelators and single
oxygen quenchers. Phenolic-enriched extracts correlate with a wide
range of physiological and health beneﬁts other than antioxidative
activity through the modulation of multiple signalling pathways
(Rodrigo et al., 2011). These features could be exploited for treatmentude extracts
lass
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species. Ozm (Ozoroa mucronata); Ozp (O. paniculosa); Sle (Searsia leptodictya); Spd
, NT (Non-tannin (mg GAE/g)), CT (Condensed tannin (mg CE/g)), PA (proanthocyanidin
/g)).
14 A.S. Ahmed et al. / South African Journal of Botany 95 (2014) 9–18of multi-causal diseases such as diarrhoea with one or more combina-
tions of aetiologies including microbial infection, stress, allergy, inﬂam-
mation, immune dysfunctions.
The extracts of O. paniculosa which had the highest total phenols,
contained relatively low levels of total tannin with the highest amount
obtained from S. pendulina (254.03 ± 4.42 mg GAE/g dried plant mate-
rial) followed by O. paniculosa (230.97 ± 10.71 mg GAE/g dried plant
material). Extracts of O. mucronata, whose total phenolic content was
lowest, also ranked last on the total tannin content (27.15 ± 0.18 mg
GAE/g dried plant material). The tannin constituents are mostly of the
proanthocyanidin type with the highest amount obtained from
S. leptodictya (126.54 ± 6.46 mg LE/g plant material) followed by
S. pendulina (117.83 ± 2.24 mg LE/g plant material) and the least
amount was obtained from S. pentheri (10.08 ± 2.41 mg LE/g plant ma-
terial). Interestingly, the Ozoroa species contained relatively high
gallotannin (hydrolysable tannin) with the highest amount obtained
fromO. paniculosa (75.11±1.38mgGAE/g dried plantmaterial) follow-
ed byO. mucronata (16.78± 0.61mg GAE/g dried plant material) while
Searsia species have low gallotannin and ranged from 3.24 ± 0.16 mg
GAE/g dried plant material in S. pendulina to 4.96 ± 0.38 mg GAE/g
dried plant material in S. pentheri.
The highest levels of total ﬂavonoids were obtained in extracts of
O. paniculosa (168.27 ± 4.12 mg QE/g plant material) followed by
O. mucronata (73.07 ± 11.25 mg QE/g plant material). The extracts of
S. leptodictya and S. pendulina, which had high total phenolic contents,
contained relatively low levels of total ﬂavonoid contents of 19.18 ±
1.15 and 31.44± 1.87mgQE/g plantmaterial respectively. The ﬂavonol
contents of all the extracts were low and ranged from 1.69 ± 0.08 mg
QE/g plant material in S. leptodictya to 2.36± 0.09mg QE/g plant mate-
rial in S. pentheri.
3.3. Antimicrobial activities of the crude extracts and fractions
The crude extract and fractions of various polarities from the leaf
extracts of Ozoroa and Searsia species tested in this study had a broad
spectrum of microbial growth inhibition. For volatile oils minimum
inhibitory concentrations of 0.28–1.27 mg/ml are considered as
“extremely high activity” (Aligiannis et al., 2001). For plant extracts
there appear to be reasonable consensus that only MICs of less than
0.1 mg/ml are pharmacologically interesting (Eloff, 2004; Rios and
Recio, 2005). In this study where extracts could potentially be dosedTable 1
Minimum Inhibitory Concentration (MIC) of theOzoroa and Searsia species expressed in μg/ml a
Ozoroa mucronata Ozoroa paniculosa
E. c E. f P. a S. a C. a C. n A. f E. c E. f P. a
Cru 1250 625 312 2500 625 156 625 1250 1250 156
Hex 78 39 156 19 312 312 39 78 39 39
DCM 39 19 39 19 156 156 156 39 19 39
ET 156 625 312 625 156 39 39 39 156 78
B 312 1250 2500 1250 625 156 156 625 78 156
W 625 2500 1250
Searsia pendulina
E. c E. f P. a S. a C. a C. n A. f
Cru 1250 625 625 312 625 312 625
Hex 39 156 78 78 39 156 78
DCM 39 19 78 78 78 39 39
ET 78 312 19 39 156 39 156
B 1250 625 2500 625 625 156 78
W 625 625 312
Gent 0.39 0.78 1.56 0.78 – – –
Amp B – – – – 6.25 3.12 0.78
N.B.: Cru = crude extract, Hex = hexane fraction, DCM= dichloromethane fraction, ET = eth
Enterococcus faecalis, P. a = Pseudomonas aeruginosa, S. a = Staphylococcus aureus, A. f = Asp
gentamicin, Amp B = amphotericin B.to animals, the activity of the samples were classiﬁed as pharmacologi-
cally interesting if theMIC was less than 100 μg/ml, good if theMIC was
between 100 and 200 μg/ml, moderate if theMICwas between 200 and
625 μg/ml, weak for MICs of 625–1000 μg/ml and inactive if the MIC
was greater than 1000 μg/ml (Eloff, 2004; Kuete, 2010). The antibacte-
rial activities of the test samples against ATCC strains of E. coli, E. faecalis,
P. aeruginosa and S. aureus are summarised in Table 1. The hexane and
DCM fractions of all the plant species had varying antibacterial activities
with MIC values ranging between 19 and 1250 μg/ml. The polar frac-
tions (ethyl acetate and butanol) also had moderate to good antibacte-
rial activities with MIC values ranged between 39 and 625 μg/ml.
However, some of the organisms were resistance to the crude extracts
and residual water fractions with MICs ranging between 312 and
above 2500 μg/ml.
Increasing new fungal infections and the emergence of resistant
strains in humans and animals now pose a serious health problem
worldwide. Opportunistic fungal infections have also becomemore im-
portant especially due to the immune deﬁciency induced by HIV/AIDS
(Groll et al., 1996). The antifungal activities of the extracts and fractions
are presented in Table 1 against clinical pathogenic strains of C. albicans,
A. fumigatus, and C. neoformans. The antifungal activities of theﬁve plant
species were potentiated in the hexane and DCM fractions with MICs
ranging between 39 and 625 μg/ml. The ethyl acetate and butanol frac-
tions also had moderate to good antifungal activities with MICs ranging
between 78 and 1250 μg/ml. The residual water fraction had poor to no
activity against some fungal strains, especially C. albicans. In a related
study, the non-polar extracts of Combretum vendae (A.E. van Wyk)
(Combretaceae), Khaya anthotheca (Welm.) C. DC (Meliaceae) and
Ochna natalitia (Meisn.)Walp. (Ochnaceae) have good activities against
some selectedmicroorganismswithMIC values ranged between 50 and
90 μg/ml (Suleiman et al., 2010).
The antimicrobial activity of extracts generally depends on the plant
phytochemical composition, extracting solvent, effective solubility and
miscibility of the active component in the test medium, the vulnerability
of the test organisms, and the method used in evaluation. Antimicrobial
components of the plants tested in this study are concentrated in
the non-polar fractions. Many other studies have also reported the ex-
ceptional antimicrobial activities of non-polar extracts and fractions
(Kotze and Eloff, 2002; Matu and Van Staden, 2003; Eloff et al., 2005a,
2005b), suggesting that the antimicrobial agents are concentrated
in these fractions. Thus, for infectious diarrhoea, plant decoctions,gainst some bacteria and fungi associatedwith GIT infectious diseases including diarrhoea.
Searsia leptodictya
S. a C. a C. n A. f E. c E. f P. a S. a C. a C. n A. f
156 312 78 312 1250 625 625 312 312 156 625
19 156 312 78 39 39 39 19 39 156 78
19 78 39 78 39 19 39 19 39 39 39
78 156 39 312 78 156 39 78 ND ND ND
156 312 156 156 2500 625 625 312 312 312 156
625 1250 625 625 1250 312
Searsia pentheri
E. c E. f P. a S. a C. a C. n A. f
2500 1250 156 312 2500 312 2500
39 39 19 19 625 1250 78
39 19 19 19 78 19 19
156 156 78 156 312 39 625
2500 1250 2500 312 156 312 156
1250 1250 625
yl acetate fraction, B = butanol fraction, W=water fraction, E. c= Escherichia coli, E. f=
ergillus fumigatus, C. a= Candida albicans and C. n = Cryptococcus neoformans, Gent =
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15A.S. Ahmed et al. / South African Journal of Botany 95 (2014) 9–18concoctions or infusions usually used in traditional medicine may be
ineffective except as supportive therapy in the case of oxidative
stress or inﬂammatory involvement. The use of alcoholic solutions
which may extract a broad spectrum of compounds is recommended
instead of water extracts.
In infectious diarrhoea, many bacteria, protozoa, viruses and para-
sites have been implicated as causative agents. These agents include
Vibrio cholera, E. coli, Shigella dysenteriae, Bacillus cereus, S. aureus, Clos-
tridium difﬁcile, Entamoeba histolytica, Salmonella typhi and Giardia
lamblia (Laohachai et al., 2003; Kelly, 2011). Some viruses such as rota-
virus and adenovirus have also been implicated as causative agents of
diarrhoeal diseases. The infectious mechanisms of the pathogenic
strains of the enteric microbes include microbial attachment, localised
effacement of the epithelial mucosa lining, production and elaboration
of secretory enterotoxins, production of cell-destroying cytotoxins,
and direct epithelial cell invasion. In this study, the emphasis was on
E. coli, S. aureus, E. faecalis and C. albicans as diarrhoeal pathogens.
Seven virulence groups of diarrhoeagenic E. coli, namely enteropatho-
genic E. coli (EPEC), enterohaemorrhagic E. coli (EHEC), enteroinvasive
E. coli (EIEC), enterotoxigenic E. coli (ETEC), enteroaggregative E. coli
(EAggEC), diarrhoea-associated haemolytic E. coli (DHEC) and cytolethal
distending toxin (CDT)-producing E. coli have been classiﬁed (Clarke,
2001). On a global scale EPEC, EHEC, ETEC and EIEC are themost impor-
tant diarrhoeal agents, accounting for 4–8%, 0–1%, 12–20% and 0–2%
respectively in terms of total episodes (Bhan, 2000). The virulence
mechanisms of ETEC, EHEC, S. aureus, E. faecalis and some strains of
V. cholerae include production of endotoxin, cytotoxins and ROS. The
use of antimicrobial therapy may not be effective in the diarrhoea
cases involving these organisms because the toxins, if already present
in contaminated food orwater, do not need the pathogens to exert activ-
ity. Therefore, non-antimicrobial therapymay be required in such cases.
The effective antimicrobial activities of the hexane and DCM frac-
tions, and the moderate activities of the ethyl acetate and butanol
fractions justify the application of the organic extracts of the plant
species in treating infectious diarrhoea. The mechanism of action
may be microbicidal or microbiostatic. However, targeting speciﬁc
pathways such as anti-toxigenic, antioxidative, anti-inﬂammatory,
antisecretory and pro-absorptive activities of the medicinal plant
extracts provides novel approaches to combating diarrhoea.Ta
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.3.4. Antioxidant
The concentration-dependent DPPH scavenging activity of the crude
extracts and fractions of various polarities expressed as EC50 are pre-
sented in Table 2. The radical scavenging activities are potentiated in
the crude extract, and polar fractionswith the ethyl acetate and butanol
fractions exhibiting activities comparable to the reference controls
(ascorbic acid and trolox). The hexane and DCM fractions results re-
vealed limited DPPH radical scavenging ability, indicating that the
non-polar components present in the fractions are low radical scav-
engers. The mechanism of DPPH radical scavenging is through hy-
drogen transfer from the extract to DPPH, forming yellow coloured
reduced adducts of DPPH-H. A high DPPH radical scavenging capac-
ity is an indication of the hydrogen donating potential of the bioac-
tive components of the extracts and these relate directly to the
number of free phenolic hydroxyl groups and their position in the
molecule.
The concentration-dependent DPPH scavenging activity of the crude
extracts and fractions of various polarities expressed as EC50 are pre-
sented in Table 2. The mechanism of ABTS radical scavenging effect is
by electron transfer from the extracts to blue-green ABTS+ to form
decolourised ABTS molecule. The crude extract, ethyl acetate and buta-
nol fractions of all the Ozoroa and Searsia species had good radical scav-
enging capacity while the hexane and DCM fraction activities were
weak. Apart from giving an insight into the mechanistic pathway of
Table 3
Cytotoxicity, linoleic acid peroxidation and lipoxygenase inhibition of acidiﬁed 70% acetone crude extracts.
Plant species Cytotoxicity
(LC50 (μg/ml))
Linoleic acid peroxidation
inhibition (LC50 (μg/ml))
Lipoxygenase enzyme
inhibition (LL50 (μg/ml))
Ozoroa mucronata 741.91 ± 44.20 13.95 ± 2.23 32.02 ± 12.00
Ozoroa paniculosa 16.58 ± 1.85 25.2 ± 8.10 286 ± 94.40
Searsia leptodictya 25.09 ± 2.40 40.45 ± 13.38 122.67 ± 27.86
Searsia pendulina 22.30 ± 2.46 30.21 ± 5.49 –
Searsia pentheri 50.62 ± 4.33 25.53 ± 6.20 97.61 ± 21.71
Berberine chloride (positive control) 4.74 ± 0.41
16 A.S. Ahmed et al. / South African Journal of Botany 95 (2014) 9–18antioxidant activity of extracts, the ABTS and DPPH radical scavenging
assay have no biological relevance.
The crude extracts and the polar fractions (ethyl acetate and buta-
nol) had good concentration-dependent hydroxyl ion scavenging ca-
pacity. The results are calculated as percentage radical scavenged and
from the plot best ﬁt curve of log concentration against percentage inhi-
bition, the EC50 were calculated and are presented in Table 2. Hydroxyl
radicals are highly reactive species, which react non-selectively with
bio-molecules such as DNA, proteins and membrane phospholipids to
cause tissue damage and dysfunction. The body immunology and
other metabolic biochemical pathways generate oxidative molecules
such as superoxide, hydrogen peroxide and nitric oxide as defence
mechanisms or signalling agents. However, overproduction of the reac-
tive species results in oxidative stress. Although, superoxide and hydro-
gen peroxide areweakoxidizingmolecules, in the presence of transition
metal catalysts like Fe3+ or Cu2+, they generate hydroxyl radicals.
Therefore, extracts or components with good hydroxyl ion scavenging
ability can help with degenerative diseases in which this reactive spe-
cies is an initiator, such as inﬂammatory diarrhoea.
Lipid peroxidation (LPO) is a chain reaction process of radical attack
on the membrane and other phospholipid constituents of the cell. The
thiobarbituric method determines the amount of peroxide in the reac-
tion medium, as peroxide is the main product generated in lipid perox-
idation. The dose-dependent inhibition of linoleic acid peroxidation
processes of the crude extracts are presented in Table 3. The results
expressed as LC50 range from 13.95 ± 2.23 to 40.45 ± 13.38 μg/ml.
The inhibition of lipid peroxidation may be due to termination of the
radical chain reaction after its propagation by scavenging highly
toxic lipid peroxy radicals. Peroxidation of membrane phospholipids,Inhibition of  15-soybean lipoxygenase enzyme by 
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Fig. 3. Percentage inhibition of the soybean 15-lipoxygenase enzyme by the crude extracts. N.B.:
Spt (S. pentheri).including intestinal epithelial tissue, can distort the assembly of the
membrane, causing changes in ﬂuidity and permeability, alterations of
ion transport and inhibition of metabolic processes (Nigam and
Schewe, 2000). Many cytolytic compounds such as reactive aldehyde
products, including malondialdehyde (MDA), 4-hydroxy-2-nonenal
(HNE), 4-hydroxy-2-hexenal (4-HHE) and acrolein are produced asme-
tabolites of lipid peroxidation (Esterbauer et al., 1991). These metabo-
lites inﬂict injury and cause malfunctioning of the tissues. In addition,
LPO generate more ROS, causing exacerbation of oxidative stress. Com-
bined effects of LPO deleterious mechanisms in the GIT results in intes-
tinal inﬂammation (Stojiljkovic et al., 2009), and consequently
diarrhoea unless efﬁcient inhibition mechanisms of the processes are
in place. The good LPO inhibitory activity of the phenolic-enriched ex-
tracts of the Ozoroa and Searsia species tested in this work indicate
that the plant have potential as supportive therapy in diarrhoea
episodes.
3.5. Inhibition of soybean 15-lipoxygenase
All the extracts had poor anti-inﬂammatory activity when evaluat-
ing percentages of lipoxygenase inhibition, except O. mucronata,
which displayed moderate activity (IC50 value: 32.02 ± 12.00 μg/ml)
(See Fig. 3). The IC50 values of theO. paniculosa and S. leptodictya against
the soybean 15-lipoxygenase enzymewere higher than 100 μg/ml com-
pared to the positive control (quercetin) as presented in Table 3. The
lipoxygenases have been implicated in a number of pathological states,
and LOX products stimulate neutrophil migration, increase adhesion of
leukocytes to endothelial cells, cause smooth muscle contraction, in-
crease vascular permeability, and increase ion and mucus secretionselected Ozoroa and Searsia species
 (mg/ml)
0.0
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useful for the treatment of human and animal inﬂammatory conditions.
Inhibition of soybean 15-lipoxygenase is generally regarded as predic-
tive for inhibition of the mammalian enzyme (Gleason et al., 1995;
Gundersen et al., 2003; Lapenna et al., 2003).
Compounds used as antioxidant therapy may also be effective
against inﬂammation (Sala et al., 2003). The results suggest that the
components of the extract responsible for the antioxidant activity are
not necessarily those responsible for the anti-inﬂammatory activity.
However, it is hypothesised that polar extracts exhibit poor LOX inhibi-
tion but good antiradical activity while non-polar extracts exhibit good
LOX inhibition but poor antiradical activity. However, the ‘near absence’
of 15-lipoxygenase inhibitory activity in this study does not imply that
the extracts do not had any anti-inﬂammatory activity as activity may
be observed at higher concentrations. It is important to note that in-
ﬂammation involves a multiple cascade of events, involving not only
the 15-lipoxygenase pathway, but also the 5- and 12-lipoxygenases, as
well as cyclooxygenase-1, cyclooxygenase-2, cytochrome P450 and
epoxygenase pathway. It is possible for the extracts to exhibit good ac-
tivities against some of these other inﬂammatory pathways in addition
to their good antioxidant properties.3.6. Cytotoxicity
Cytotoxicity of the phenolic-enriched crude extracts is present-
ed as LC50 in Table 3. The extracts had some level of toxicity, except
for O. mucronata with an LC50 of 741.91 μg/ml and the most toxic
was O. paniculosa (LC50 = 16.58 μg/ml) followed by S. pendulina
(LC50 = 22.30 μg/ml). The LC50 values for S. leptodictya and S. pentheri
were 25.09 and 50.62 μg/ml respectively. The toxicity threshold level
for extracts is LC50 less than 20 μg/ml (Zirihi et al., 2005), therefore,
the phenolic-enriched extracts of O. paniculosa, S. pendulina, and
S. leptodictya need to be applied orally with caution unless the
fraction(s) containing toxic component(s) is identiﬁed and removed.
It is interesting to note that the toxicity levels of the two Ozoroa species
differed so extensively, but these species may have quite different
chemical compositions to account for this discrepancy.4. Conclusion
Medicinal plant-derived phytochemical preparations exhibiting
multiple bioactivities such as broad-based antimicrobial, antioxidative,
radical scavenging and anti-inﬂammatory activity have potential for
treating diseases with multi-factorial pathoaetiologies like diarrhoea.
Crude extracts and fractions of the Ozoroa and Searsia species show
high activity both as radical scavengers and lipoxygenase inhibitors,
and it is possible that these activities may be involved in their putative
medicinal properties. The cytotoxicity of the crude extracts are low
comparedwith berberine chloride (Sigma)whichwas used as a positive
control, indicating that the plants have some level of safety though their
use needs to be monitored (dosage) to avoid exceeding the toxicity
limits. However, in vivo studies are necessary to determine the ther-
apeutic and toxic effects of these extracts in normal physiological
situations as in vitro studies results are not usually a true, complete
reﬂection of drug action.Acknowledgement
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